Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment

A synaptic model of memory: long-term potentiation in the hippocampus

Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566 · see citing works

Place navigation impaired in rats with hippocampal lesions

Morris, R. G. M., Garrud, P., Rawlins, J. N. P., & O'Keefe, J. (1982) · Nature · doi:10.1038/297681a0 · Cited by 6,340 · see citing works

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · see citing works

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works

Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles

Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126 · see citing works

Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.

Phillips, R. G., & LeDoux, J. E. (1992) · Behavioral Neuroscience · doi:10.1037/0735-7044.106.2.274 · Cited by 3,292 · see citing works

Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.

Phillips, R. G., & LeDoux, J. E. (1992) · Behavioral Neuroscience · doi:10.1037//0735-7044.106.2.274 · Cited by 3,262 · see citing works

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160 · see citing works

Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein

Bourtchuladze, R., Frenguelli, B., Blendy, J., Cioffi, D., Schutz, G., & Silva, A. J. (1994) · Cell · doi:10.1016/0092-8674(94)90400-6 · Cited by 1,800 · see citing works

Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C. A., Hardy, J., Duff, K., Jantzen, P. T., DiCarlo, G., Wilcock, D. M., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,488 · see citing works

Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects

Nehlig, A., Daval, J., & Debry, G. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90012-b · Cited by 1,463 · see citing works

Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1

Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,453 · see citing works

Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397 · see citing works

ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease

Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303 · see citing works

Intraneuronal Aβ42 Accumulation in Human Brain

Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J. P., Haroutunian, V., Buxbaum, J. D., Xu, H., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64700-1 · Cited by 991 · see citing works

Induction of a dominant negative CREB transgene specifically blocks long-term memory in Drosophila

Yin, J. C. P., Wallach, J. S., Del Vecchio, M., Wilder, E. L., Zhou, H., Quinn, W. G., & Tully, T. (1994) · Cell · doi:10.1016/0092-8674(94)90399-9 · Cited by 959 · see citing works

Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model

Dodart, J.-C., Bales, K. R., Gannon, K. S., Greene, S. J., DeMattos, R. B., Mathis, C., DeLong, C. A., Wu, S., Wu, X., Holtzman, D. M., et al. (2002) · Nature Neuroscience · doi:10.1038/nn842 · Cited by 858 · see citing works

Spatial mapping: definitive disruption by hippocampal or medial frontal cortical damage in the rat.

Sutherland, R., Kolb, B., & Whishaw, I. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90032-5 · Cited by 573 · see citing works

Neuropathology and Pathogenesis of Encephalitis following Amyloid β Immunization in Alzheimer's Disease

Ferrer, I., Boada, M., Guerra, M. L. S., Rey, M. J., & Costa‐Jussà, F. R. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00493.x · Cited by 567 · see citing works

Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway

Bach, M. E., Barad, M., Son, H., Zhuo, M., Lü, Y.-F., Shih, R., Mansuy, I. M., Hawkins, R. D., & Kandel, E. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5280 · Cited by 561 · see citing works

Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling

Vitolo, O. V., Sant'Angelo, A., Costanzo, V., Battaglia, F., Arancio, O., & Shelanski, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172504199 · Cited by 534 · see citing works

Regulation of Neurogenesis in Adult Mouse Hippocampus by cAMP and the cAMP Response Element-Binding Protein

Nakagawa, S., Kim, J., Lee, R., Malberg, J. E., Chen, J., Steffen, C., Zhang, Y., Nestler, E. J., & Duman, R. S. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03673.2002 · Cited by 486 · see citing works

The Role of the Extracellular Signal-Regulated Kinase Signaling Pathway in Mood Modulation

Einat, H., Yuan, P., Gould, T. D., Li, J., Du, J., Zhang, L., Manji, H. K., & Chen, G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-19-07311.2003 · Cited by 475 · see citing works

Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory

Barad, M., Bourtchouladze, R., Winder, D. G., Golan, H. M., & Kandel, E. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.15020 · Cited by 431 · see citing works

Dissociation between components of spatial memory in rats after recovery from the effects of retrohippocampal lesions

Schenk, F., & Morris, R. G. M. (1985) · Experimental Brain Research · doi:10.1007/bf00238949 · Cited by 418 · see citing works

Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome

Iwatsubo, T., Mann, D. M. A., Odaka, A., Suzuki, N., & Ihara, Y. (1995) · Annals of Neurology · doi:10.1002/ana.410370305 · Cited by 380 · see citing works

Progressive age‐related development of Alzheimer‐like pathology in APP/PS1 mice

Trinchese, F., Liu, S., Battaglia, F., Walter, S., Mathews, P. M., & Arancio, O. (2004) · Annals of Neurology · doi:10.1002/ana.20101 · Cited by 369 · see citing works

Targeting the CREB pathway for memory enhancers

Tully, T., Bourtchouladze, R., Scott, R., & Tallman, J. F. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1061 · Cited by 355 · see citing works

Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes

Arendash, G. W., King, D. L., Gordon, M. N., Morgan, D., Hatcher, J. M., Hope, C. E., & Diamond, D. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03186-3 · Cited by 349 · see citing works

A mouse model of Rubinstein-Taybi syndrome: Defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4

Bourtchouladze, R., Lidge, R., Catapano, R., Stanley, J., Gossweiler, S., Romashko, D., Scott, R., & Tully, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834280100 · Cited by 313 · see citing works

Altered responsiveness to cocaine in rats exposed to methylphenidate during development

Andersen, S. L., Arvanitogiannis, A., Pliakas, A. M., LeBlanc, C., & Carlezon, W. A. (2002) · Nature Neuroscience · doi:10.1038/nn777 · Cited by 259 · see citing works

Neurofibromin regulates G protein–stimulated adenylyl cyclase activity

Tong, J., Hannan, F., Zhu, Y., Bernards, A., & Zhong, Y. (2002) · Nature Neuroscience · doi:10.1038/nn792 · Cited by 249 · see citing works

Block of LTP in rat hippocampus in vivo by β-amyloid precursor protein fragments

Cullen, W. K., Suh, Y., Anwyl, R., & Rowan, M. J. (1997) · Neuroreport · doi:10.1097/00001756-199710200-00006 · Cited by 235 · see citing works

Dysregulation of Protein Kinase A Signaling in the Aged Prefrontal Cortex

Ramos, B. P., Birnbaum, S. G., Lindenmayer, I., Newton, S. S., Duman, R. S., & Arnsten, A. F. T. (2003) · Neuron · doi:10.1016/s0896-6273(03)00694-9 · Cited by 218 · see citing works

Accelerated Plaque Accumulation, Associative Learning Deficits, and Up-regulation of α7 Nicotinic Receptor Protein in Transgenic Mice Co-expressing Mutant Human Presenilin 1 and Amyloid Precursor Proteins

Dineley, K. T., Xia, X., Bui, D., Sweatt, J. D., & Zheng, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200164200 · Cited by 212 · see citing works

Untitled work

(1995) · PubMed · Cited by 167 · see citing works

Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization.

LaFerla, F. M., Troncoso, J. C., Strickland, D. K., Kawas, C. H., & Jay, G. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119536 · Cited by 162 · see citing works

Rolipram in Major Depressive Disorder: Results of a Double-Blind Comparative Study with Imipramine

Hebenstreit, G. F., Fellerer, K., Fichte, K., Fischer, G., Geyer, N., Meya, U., Sastre-y-Hernández, M., Schöny, W., Schratzer, M., Soukop, W., et al. (1989) · Pharmacopsychiatry · doi:10.1055/s-2007-1014599 · Cited by 159 · see citing works

Inhibition of Cyclic AMP Phosphodiesterase (PDE4) Reverses Memory Deficits Associated with NMDA Receptor Antagonism

Zhang, H. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00108-1 · Cited by 154 · see citing works

Amyloid-β Antibody Treatment Leads to Rapid Normalization of Plaque-Induced Neuritic Alterations

Lombardo, J. A., Stern, E. A., McLellan, M. E., Kajdasz, S. T., Hickey, G. A., Bacskai, B. J., & Hyman, B. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10879.2003 · Cited by 149 · see citing works

Molecular Neurobiology of Human Cognition

Weeber, E. J., & Sweatt, J. D. (2002) · Neuron · doi:10.1016/s0896-6273(02)00634-7 · Cited by 145 · see citing works

Inhibition of the Phosphodiesterase 4 (PDE4) Enzyme Reverses Memory Deficits Produced by Infusion of the MEK Inhibitor U0126 into the CA1 Subregion of the Rat Hippocampus

Zhang, H., Zhao, Y., Huang, Y., Dorairaj, N. R., Chandler, L. J., & O’Donnell, J. M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300440 · Cited by 141 · see citing works

Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats

Zhang, H., & O’Donnell, J. M. (2000) · Psychopharmacology · doi:10.1007/s002130000414 · Cited by 136 · see citing works

Overexpression of<i>hAPPswe</i>Impairs Rewarded Alternation and Contextual Fear Conditioning in a Transgenic Mouse Model of Alzheimer's Disease

Corcoran, K. A., Lu, Y., Turner, R. S., & Maren, S. (2002) · Learning &amp; Memory · doi:10.1101/lm.51002 · Cited by 135 · see citing works

Ameliorating effects of rolipram on experimentally induced impairments of learning and memory in rodents

Imanishi, T., Sawa, A., Ichimaru, Y., Miyashiro, M., Kato, S., Yamamoto, T., & Ueki, S. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00969-7 · Cited by 130 · see citing works

Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia

Nicholson, C. D. (1990) · Psychopharmacology · doi:10.1007/bf02244119 · Cited by 130 · see citing works

Impairments of long-term potentiation in hippocampal slices of β-amyloid-infused rats

Itoh, A., Akaike, T., Sokabe, M., Nitta, A., Iida, R., Olariu, A., Yamada, K., & Nabeshima, T. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00601-9 · Cited by 118 · see citing works

The Type IV-Specific Phosphodiesterase Inhibitor Rolipram and Its Effect on Hippocampal Long-Term Potentiation and Synaptic Tagging

Navakkode, S., Sajikumar, S., & Frey, J. U. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1796-04.2004 · Cited by 114 · see citing works

Phosphodiesterase 4 inhibitors, structurally unrelated to Rolipram, as promising agents for the treatment of asthma and other pathologies

Piaz, V. D., & Giovannoni, M. P. (2000) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(00)00179-3 · Cited by 109 · see citing works

The effect of caffeine in animal models of learning and memory

Angelucci, M. E. M., Vital, M. A. B. F., Cesário, C., Zadusky, C. R., Rosalen, P. L., & Cunha, C. D. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00225-3 · Cited by 109 · see citing works

Caffeine reverses the memory disruption induced by intra-nigral MPTP-injection in rats

Gevaerd, M. S., Takahashi, R. N., Silveira, R., & Cunha, C. D. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00501-9 · Cited by 104 · see citing works

Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys, the rat and the rabbit. Studies on species differences

Kŕause, W., & Kühne, G. (1988) · Xenobiotica · doi:10.3109/00498258809041693 · Cited by 104 · see citing works

Receptor protein tyrosine phosphatase α is essential for hippocampal neuronal migration and long‐term potentiation

Petrone, A., Battaglia, F., Wang, C., Dusa, A., Su, J. D., Zagzag, D., Bianchi, R., Casaccia‐Bonnefil, P., Arancio, O., & Sap, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg399 · Cited by 85 · see citing works

Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism‐induced defects in memory function and cerebral cyclic AMP signal transduction system in rats

Nagakura, A., Niimura, M., & Takeo, S. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704629 · Cited by 76 · see citing works

Calpain Inhibitors, a Treatment for Alzheimer's Disease: Position Paper

Battaglia, F., Trinchese, F., Liu, S., Walter, S., Nixon, R. A., & Arancio, O. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:357 · Cited by 63 · see citing works

Abnormalities of cAMP signaling in affective disorders: implications for pathophysiology and treatment

Pérez, J., Tardito, D., Mori, S., Racagni, G., Smeraldi, E., & Zanardi, R. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.020104.x · Cited by 61 · see citing works

CREB and neurodegeneration

Dragunow, M. (2004) · Frontiers in bioscience · doi:10.2741/1197 · Cited by 40 · see citing works

Effects of caffeine on discrimination learning, consolidation, and learned behavior in mice

Castellano, C. (1976) · Psychopharmacology · doi:10.1007/bf00496858 · Cited by 34 · see citing works

Later Developments: Molecular Keys to Age-Related Memory Impairment

Barad, M. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200307000-00009 · Cited by 18 · see citing works

Pharmacokinetics of proterguride in rat and cynomolgus monkey

Kŕause, W., & Humpel, M. (1988) · Xenobiotica · doi:10.3109/00498258809055135 · Cited by 9 · see citing works

Untitled work

(1999) · doi:10.1002/(sici)1098-1063(1999)9:5

Plasticity in the human central nervous system

Cooke, S. F. (2006) · Brain · doi:10.1093/brain/awl082 · Cited by 1,195 · see citing works

Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models

Lourenco, M. V., Frozza, R. L., de Freitas, G. B., Zhang, H., Kincheski, G. C., Ribeiro, F. C., Gonçalves, R. A., Clarke, J. R., Beckman, D., Staniszewski, A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0275-4 · Cited by 935 · see citing works

Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents

Lugnier, C. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.07.003 · Cited by 873 · see citing works

Phosphodiesterase 4D Deficiency in the Ryanodine-Receptor Complex Promotes Heart Failure and Arrhythmias

Lehnart, S. E., Wehrens, X. H. T., Reiken, S. R., Warrier, S., Belevych, A. E., Harvey, R. D., Richter, W., Jin, S.-L. C., Conti, M., & Marks, A. R. (2005) · Cell · doi:10.1016/j.cell.2005.07.030 · Cited by 518 · see citing works

The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease

Ferreira, S. T., & Klein, W. L. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.08.003 · Cited by 442 · see citing works

Ubiquitin Hydrolase Uch-L1 Rescues β-Amyloid-Induced Decreases in Synaptic Function and Contextual Memory

Gong, B., Cao, Z., Zheng, P., Vitolo, O. V., Liu, S., Staniszewski, A., Moolman, D. L., Zhang, H., Shelanski, M. L., & Arancio, O. (2006) · Cell · doi:10.1016/j.cell.2006.06.046 · Cited by 424 · see citing works

The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease

Amidfar, M., de Oliveira, J., Kucharska, E., Budni, J., & Kim, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118020 · Cited by 413 · see citing works

Phosphodiesterases in the CNS: targets for drug development

Menniti, F. S., Faraci, W. S., & Schmidt, C. J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2058 · Cited by 391 · see citing works

Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model

Ricobaraza, A., Cuadrado-Tejedor, M., Pérez-Mediavilla, A., Frechilla, D., Del Río, J., & García-Osta, A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.229 · Cited by 423 · see citing works

Adenosine A2AReceptor Blockade Prevents Synaptotoxicity and Memory Dysfunction Caused by β-Amyloid Peptides via p38 Mitogen-Activated Protein Kinase Pathway

Canas, P. M., Porciúncula, L. O., Cunha, G. M. A., Silva, C. G., Machado, N. J., Oliveira, J. M. A., Oliveira, C. R., & Cunha, R. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3728-09.2009 · Cited by 358 · see citing works

Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models

Gong, B., Pan, Y., Vempati, P., Zhao, W., Knable, L., Ho, L., Wang, J., Sastre, M., Ono, K., Sauve, A. A., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.005 · Cited by 345 · see citing works

Phosphodiesterase 5 Inhibition Improves Synaptic Function, Memory, and Amyloid- Load in an Alzheimer's Disease Mouse Model

Puzzo, D., Staniszewski, A., Deng, S., Privitera, L., Leznik, E., Liu, S., Zhang, H., Feng, Y., Palmeri, A., Landry, D. W., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0864-09.2009 · Cited by 333 · see citing works

Soluble Aβ Inhibits Specific Signal Transduction Cascades Common to the Insulin Receptor Pathway

Townsend, M., Mehta, T., & Selkoe, D. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610390200 · Cited by 318 · see citing works

The role of CREB signaling in Alzheimer’s disease and other cognitive disorders

Saura, C. A., & Valero, J. (2011) · revneuro · doi:10.1515/rns.2011.018 · Cited by 312 · see citing works

Synaptic changes in Alzheimer’s disease and its models

Pozueta, J., Lefort, R., & Shelanski, M. L. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.050 · Cited by 305 · see citing works

Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-β Levels in Aged Alzheimer's Disease Mice

Arendash, G. W., Mori, T., Cao, C., Mamcarz, M., Runfeldt, M., Dickson, A., Rezai-Zadeh, K., Tan, J., Citron, B. A., Lin, X., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1087 · Cited by 308 · see citing works

Dysregulation of Histone Acetylation in the APP/PS1 Mouse Model of Alzheimer's Disease

Francis, Y. I., Fà, M., Ashraf, H., Zhang, H., Staniszewski, A., Latchman, D. S., & Arancio, O. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1134 · Cited by 296 · see citing works

Selective phosphodiesterase inhibitors: a promising target for cognition enhancement

Reneerkens, O. A. H., Rutten, K., Steinbusch, H. W. M., Blokland, A., & Prickaerts, J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1273-x · Cited by 268 · see citing works

Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease

García‐Osta, A., Cuadrado‐Tejedor, M., García, C., Oyarzábal, J., & Franco, R. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3000907 · Cited by 260 · see citing works

Lymphatic drainage system of the brain: A novel target for intervention of neurological diseases

Sun, B., Wang, L.-H., Yang, T., Sun, J., Mao, L., Yang, M., Yuan, H., Colvin, R. A., & Yang, X. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.08.007 · Cited by 255 · see citing works

Brain Slices as Models for Neurodegenerative Disease and Screening Platforms to Identify Novel Therapeutics

Cho, S., Wood, A., & Bowlby, M. R. (2007) · Current Neuropharmacology · doi:10.2174/157015907780077105 · Cited by 242 · see citing works

Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease

Ricobaraza, A., Cuadrado‐Tejedor, M., Marco, S., Pérez‐Otaño, I., & García‐Osta, A. (2012) · Hippocampus · doi:10.1002/hipo.20883 · Cited by 239 · see citing works

Reversal of long-term dendritic spine alterations in Alzheimer disease models

Smith, D. L., Pozueta, J., Gong, B., Arancio, O., & Shelanski, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908706106 · Cited by 229 · see citing works

Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons

Pugazhenthi, S., Wang, M., Pham, S. T., Sze, C., & Eckman, C. B. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-60 · Cited by 240 · see citing works

Rodent models for Alzheimer’s disease drug discovery

Puzzo, D., Gulisano, W., Palmeri, A., & Arancio, O. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1041913 · Cited by 222 · see citing works

Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms

Costa, D. A., Cracchiolo, J. R., Bachstetter, A. D., Hughes, T. F., Bales, K. R., Paul, S. M., Mervis, R. F., Arendash, G. W., & Potter, H. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.04.009 · Cited by 217 · see citing works

Exercise improves cognition and hippocampal plasticity in <i>APOE</i> ɛ4 mice

Nichol, K., Deeny, S. P., Seif, J., Camaclang, K., & Cotman, C. W. (2009) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2009.02.006 · Cited by 213 · see citing works

Behavioral assays with mouse models of Alzheimer's disease: Practical considerations and guidelines

Puzzo, D., Lee, L. S., Palmeri, A., Calabrese, G., & Arancio, O. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.011 · Cited by 214 · see citing works

Acute γ-Secretase Inhibition Improves Contextual Fear Conditioning in the Tg2576 Mouse Model of Alzheimer's Disease

Comery, T., Martone, R., Aschmies, S., Atchison, K., Diamantidis, G., Gong, X.-H., Zhou, H., Kreft, A., Pangalos, M., Sonnenberg-Reines, J., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2693-05.2005 · Cited by 204 · see citing works

Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease

Cuadrado‐Tejedor, M., Hervías, I., Ricobaraza, A., Puerta, E., Pérez-Roldán, J., García, C., Franco, R., Aguirre, N., & García‐Osta, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01517.x · Cited by 208 · see citing works

Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease

Trinchese, F., Fà, M., Liu, S., Zhang, H., Hidalgo, A., Schmidt, S. D., Yamaguchi, H., Yoshii, N., Mathews, P. M., Nixon, R. A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34254 · Cited by 205 · see citing works

Brain-Targeted Proanthocyanidin Metabolites for Alzheimer's Disease Treatment

Wang, J., Ferruzzi, M. G., Ho, L., Blount, J. W., Janle, E. M., Gong, B., Pan, Y., Gowda, G. A. N., Raftery, D., Arrieta‐Cruz, I., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6437-11.2012 · Cited by 206 · see citing works

Identification of brain‐targeted bioactive dietary quercetin‐3‐ O ‐glucuronide as a novel intervention for Alzheimer's disease

Ho, L., Ferruzzi, M. G., Janle, E. M., Wang, J., Gong, B., Chen, T., Lobo, J., Cooper, B. R., Wu, Q. L., Talcott, S. T., et al. (2012) · The FASEB Journal · doi:10.1096/fj.12-212118 · Cited by 204 · see citing works

Chapter 6 Regulation of hippocampus-dependent memory by cyclic AMP-dependent protein kinase

Abel, T., & Nguyen, P. V. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(07)00006-4 · Cited by 198 · see citing works

Neurotrophins, synaptic plasticity and dementia

Arancio, O., & Chao, M. V. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.03.013 · Cited by 193 · see citing works

Oligomeric amyloid-β peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism

Berman, D. E., Dall'Armi, C., Voronov, S. V., McIntire, L. B. J., Zhang, H., Moore, A. Z., Staniszewski, A., Arancio, O., Kim, T.-W., & Di Paolo, G. (2008) · Nature Neuroscience · doi:10.1038/nn.2100 · Cited by 199 · see citing works

The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents

van der Staay, F. J., Rutten, K., Bärfacker, L., DeVry, J., Erb, C., Heckroth, H., Karthaus, D., Tersteegen, A., van Kampen, M., Blokland, A., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.005 · Cited by 180 · see citing works

Environmental Novelty Activates β2-Adrenergic Signaling to Prevent the Impairment of Hippocampal LTP by Aβ Oligomers

Li, S., Jin, M., Zhang, D., Yang, T., Koeglsperger, T., Fu, H., & Selkoe, D. J. (2013) · Neuron · doi:10.1016/j.neuron.2012.12.040 · Cited by 177 · see citing works

Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders

Valor, L. M., Viosca, J., López‐Atalaya, J. P., & Barco, Á. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990382 · Cited by 168 · see citing works

The expanding role of BDNF: a therapeutic target for Alzheimer's disease?

Fumagalli, F., Racagni, G., & Riva, M. A. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500337 · Cited by 173 · see citing works

Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer’s disease

Prickaerts, J., Heckman, P. R. A., & Blokland, A. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1364360 · Cited by 172 · see citing works

The Ubiquitin-Proteasome System: Potential Therapeutic Targets for Alzheimer’s Disease and Spinal Cord Injury

Gong, B., Radulovic, M., Figueiredo‐Pereira, M. E., & Cardozo, C. P. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00004 · Cited by 167 · see citing works

Long-term green tea catechin administration prevents spatial learning and memory impairment in senescence-accelerated mouse prone-8 mice by decreasing Aβ1-42 oligomers and upregulating synaptic plasticity–related proteins in the hippocampus

Li, Q., Zhao, H., Zhang, Z. F., Liu, Z. G., Pei, X., Wang, J. B., & Li, Y. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.07.014 · Cited by 165 · see citing works

Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer’s Disease

Yang, J., Wang, Z., Cai, H.-Y., Li, Y., Hu, M.-M., Wu, M., & Qi, J. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0268-9 · Cited by 161 · see citing works

Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model

Fang, F., Chen, X., Huang, T., Lue, L., Luddy, J. S., & Yan, S. S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.004 · Cited by 160 · see citing works

Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome

Voronov, S. V., Frere, S. G., Giovedi, S., Pollina, E. A., Borel, C., Zhang, H., Schmidt, C., Akeson, E. C., Wenk, M. R., Cimasoni, L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803756105 · Cited by 174 · see citing works

Etazolate, a neuroprotective drug linking GABAA receptor pharmacology to amyloid precursor protein processing

Marcade, M., Bourdin, J., Loiseau, N., Peillon, H., Rayer, A., Drouin, D., Schweighoffer, F., & Désiré, L. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05396.x · Cited by 155 · see citing works

Ibudilast (AV-411)

Ledeboer, A., Hutchinson, M. R., Watkins, L. R., & Johnson, K. W. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.7.935 · Cited by 153 · see citing works

Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice

Zhang, J., Guo, J., Zhao, X., Chen, Z., Wang, G., Liu, A., Wang, Q., Zhou, W., Xu, Y., & Wang, C. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.05.017 · Cited by 152 · see citing works

Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain

Kelly, M. P. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.11.004 · Cited by 147 · see citing works

The phosphodiesterase-4 inhibitor rolipram reverses Aβ-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats

Wang, C., Yang, X., Zhuo, Y., Zhou, H., Lin, H.-B., Cheng, Y., Xu, J., & Zhang, H. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000836 · Cited by 150 · see citing works

PDE4 as a target for cognition enhancement

Richter, W., Menniti, F. S., Zhang, H., & Conti, M. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.818656 · Cited by 148 · see citing works

Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer’s disease

Branca, C., Ferreira, E., Nguyen, T.-V., Doyle, K., Caccamo, A., & Oddo, S. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx361 · Cited by 139 · see citing works

Synaptic Therapy in Alzheimer's Disease: A CREB-centric Approach

Teich, A. F., Nicholls, R. E., Puzzo, D., Fiorito, J., Purgatorio, R., Fà, M., & Arancio, O. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0327-5 · Cited by 147 · see citing works

Modulation of the cAMP signaling pathway after traumatic brain injury

Atkins, C. M., Oliva, A. A., Alonso, O. F., Pearse, D. D., Bramlett, H. M., & Dietrich, W. D. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.08.011 · Cited by 140 · see citing works

GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses

Bruno, O., Fedele, E., Prickaerts, J., Parker, L. A., Canepa, E., Brullo, C., Cavallero, A., Gardella, E., Balbi, A., Domenicotti, C., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01524.x · Cited by 138 · see citing works

Hippocampal synaptic plasticity in Alzheimer’s disease: what have we learned so far from transgenic models?

Marchetti, C., & Marie, H. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.035 · Cited by 133 · see citing works

Nobiletin restoring β-amyloid-impaired CREB phosphorylation rescues memory deterioration in Alzheimer's disease model rats

Matsuzaki, K., Yamakuni, T., Hashimoto, M., Haque, A. M., Shido, O., Mimaki, Y., Sashida, Y., & Ohizumi, Y. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.02.077 · Cited by 135 · see citing works

Down‐regulation of cAMP‐dependent protein kinase by over‐activated calpain in Alzheimer disease brain

Liang, Z., Liu, F., Grundke, I., Iqbal, K., & Gong, C. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04942.x · Cited by 134 · see citing works

Spines, plasticity, and cognition in Alzheimer's model mice

Spires-Jones, T., & Knafo, S. (2012) · Neural Plasticity · doi:10.1155/2012/319836 · Cited by 133 · see citing works

FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP/PS1 transgenic mice via cAMP/PKA/CREB signaling and anti-inflammatory effects

Guo, H., Cheng, Y., Wang, C., Wu, J., Zou, Z., Niu, B., Yu, H. M., Wang, H., & Xu, J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.004 · Cited by 133 · see citing works

Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action

Rutten, K., Prickaerts, J., & Blokland, A. (2005) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2005.09.002 · Cited by 132 · see citing works

Alzheimer's β-Secretase (BACE1) Regulates the cAMP/PKA/CREB Pathway Independently of β-Amyloid

Chen, Y., Huang, X., Zhang, Y., Rockenstein, E. M., Bu, G., Golde, T. E., Masliah, E., & Xu, H. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0757-12.2012 · Cited by 131 · see citing works

Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer’s Disease

Wu, Y., Li, Z., Huang, Y., Wu, D., & Luo, H. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01370 · Cited by 129 · see citing works

-Amyloid Disrupts Activity-Dependent Gene Transcription Required for Memory through the CREB Coactivator CRTC1

España, J., Valero, J., Miñano-Molina, A. J., Masgrau, R., Martín, E., Guardia‐Laguarta, C., Lleó, A., Giménez‐Llort, L., Rodrı́guez-Álvarez, J., & Saura, C. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2154-10.2010 · Cited by 127 · see citing works

Targeting multiple pathogenic mechanisms with polyphenols for the treatment of Alzheimer's disease-experimental approach and therapeutic implications

Wang, J., Bi, W., Cheng, A., Freire, D., Vempati, P., Zhao, W., Gong, B., Janle, E. M., Chen, T., Ferruzzi, M. G., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00042 · Cited by 126 · see citing works

Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D

Sierksma, A. S. R., van den Hove, D., Pfau, F., Philippens, M., Bruno, O., Fedele, E., Ricciarelli, R., Steinbusch, H. W. M., Vanmierlo, T., & Prickaerts, J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.015 · Cited by 125 · see citing works

The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain

Ledeboer, A., Liu, T., Shumilla, J. A., Mahoney, J. H., Vijay, S., Gross, M. I., Vargas, J. A., Sultzbaugh, L., Claypool, M. D., Sanftner, L. M., et al. (2006) · Neuron Glia Biology · doi:10.1017/s1740925x0700035x · Cited by 122 · see citing works

Multitarget Therapeutic Strategies for Alzheimer’s Disease: Review on Emerging Target Combinations

Maramai, S., Benchekroun, M., Gabr, M. T., & Yahiaoui, S. (2020) · BioMed Research International · doi:10.1155/2020/5120230 · Cited by 121 · see citing works

Phosphodiesterase-4 (PDE4) Molecular Pharmacology and Alzheimer's Disease

Gurney, M. E., D'Amato, E. C., & Burgin, A. B. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0309-7 · Cited by 121 · see citing works

Current therapeutic targets for the treatment of Alzheimer’s disease

Grill, J. D., & Cummings, J. L. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.29 · Cited by 121 · see citing works

Enhanced long‐term potentiation and impaired learning in phosphodiesterase 4D‐knockout (PDE4D−/−) mice

Rutten, K., Misner, D., Works, M. G., Blokland, A., Novak, T. J., Santarelli, L., & Wallace, T. L. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06349.x · Cited by 119 · see citing works

Advances in the Development of Phosphodiesterase-4 Inhibitors

Peng, T., Qi, B., He, J., Ke, H., & Shi, J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02170 · Cited by 119 · see citing works

Stimulation of PGE2 receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following β‐amyloid exposure

Echeverrı́a, V., Clerman, A., & Doré, S. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04427.x · Cited by 119 · see citing works

Mitochondrial Mislocalization Underlies Aβ42-Induced Neuronal Dysfunction in a Drosophila Model of Alzheimer's Disease

Iijima‐Ando, K., Hearn, S., Shenton, C., Gatt, A., Zhao, L., & Iijima, K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008310 · Cited by 119 · see citing works

Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease

DeMarch, Z., Giampà, C., Patassini, S., Bernardi, G., & Fusco, F. R. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.010 · Cited by 117 · see citing works

(−)-Epigallocatechin-3-Gallate Ameliorates Learning and Memory Deficits by Adjusting the Balance of TrkA/p75NTR Signaling in APP/PS1 Transgenic Mice

Liu, M., Chen, F., Sha, L., Wang, S., Lin, T., Yao, L., He, M., Yao, Z., Liu, H., Zhu, Z., et al. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8608-2 · Cited by 117 · see citing works

Phosphodiesterase Inhibitors Enhance Object Memory Independent of Cerebral Blood Flow and Glucose Utilization in Rats

Rutten, K., van Donkelaar, E. L., Ferrington, L., Blokland, A., Bollen, E., Steinbusch, H. W. M., Kelly, P. A., & Prickaerts, J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.24 · Cited by 114 · see citing works

Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease

Giralt, A., Saavedra, A., Carretón, O., Xifró, X., Alberch, J., & Pérez‐Navarro, E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr351 · Cited by 113 · see citing works

Optogenetic stimulation of dentate gyrus engrams restores memory in Alzheimer's disease mice

Perusini, J. N., Cajigas, S. A., Cohensedgh, O., Lim, S. C., Pavlova, I. P., Donaldson, Z. R., & Denny, C. A. (2017) · Hippocampus · doi:10.1002/hipo.22756 · Cited by 115 · see citing works

Phosphodiesterase Inhibitors for Alzheimer’s Disease: A Systematic Review of Clinical Trials and Epidemiology with a Mechanistic Rationale

Sanders, O. D., & Rajagopal, L. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200191 · Cited by 115 · see citing works

Synthesis of quinoline derivatives: Discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease

Fiorito, J., Saeed, F., Zhang, H., Staniszewski, A., Feng, Y., Francis, Y. I., Rao, S. R., Thakkar, D. M., Deng, S., Landry, D. W., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.12.009 · Cited by 113 · see citing works

Phosphodiesterase‐5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition

Peixoto, C. A., Nunes, A. K. S., & García‐Osta, A. (2015) · Mediators of Inflammation · doi:10.1155/2015/940207 · Cited by 112 · see citing works

The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses

Vanmierlo, T., Creemers, P., Akkerman, S., van Duinen, M. A., Sambeth, A., Vry, J. D., Uz, T., Blokland, A., & Prickaerts, J. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.01.031 · Cited by 112 · see citing works

ADDLs and the signaling web that leads to Alzheimer’s disease

Krafft, G. A., & Klein, W. L. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.012 · Cited by 111 · see citing works

Targeting Synaptic Plasticity in Experimental Models of Alzheimer’s Disease

Mango, D., Saidi, A., Cisale, G. Y., Feligioni, M., Corbo, M., & Nisticò, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00778 · Cited by 109 · see citing works

Subchronic Rolipram Delivery Activates Hippocampal CREB and Arc, Enhances Retention and Slows Down Extinction of Conditioned Fear

Monti, B., Berteotti, C., & Contestabile, A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300813 · Cited by 109 · see citing works

Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders

Bhat, A., Ray, B., Mahalakshmi, A. M., Tuladhar, S., Nandakumar, D., Srinivasan, M., Essa, M. M., Chidambaram, S. B., Guillemin, G. J., & Sakharkar, M. K. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105078 · Cited by 107 · see citing works

Evidence of Aβ‐ and transgene‐dependent defects in ERK‐CREB signaling in Alzheimer’s models

Ma, Q., Harris‐White, M. E., Ubeda, O. J., Simmons, M., Beech, W. K., Lim, G. P., Teter, B., Frautschy, S. A., & Cole, G. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04869.x · Cited by 110 · see citing works

Phosphodiesterases in the Central Nervous System: Implications in Mood and Cognitive Disorders

Xu, Y., Zhang, H., & O’Donnell, J. M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17969-3_19 · Cited by 104 · see citing works

Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment

Choi, C. H., Schoenfeld, B. P., Bell, A. J., Hinchey, P., Kollaros, M., Gertner, M. J., Woo, N. H., Tranfaglia, M. R., Bear, M. F., Zukin, R. S., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.11.032 · Cited by 104 · see citing works

Crtc1 Activates a Transcriptional Program Deregulated at Early Alzheimer's Disease-Related Stages

Parra‐Damas, A., Valero, J., Chen, M., España, J., Martín, E., Ferrer, I., Rodrı́guez-Álvarez, J., & Saura, C. A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5288-13.2014 · Cited by 104 · see citing works

Amyloid β peptide adversely affects spine number and motility in hippocampal neurons

Shrestha, B. R., Vitolo, O. V., Joshi, P., Lordkipanidze, T. G., Shelanski, M. L., & Dunaevsky, A. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.07.011 · Cited by 103 · see citing works

Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25–35 or Aβ1–40 peptide in rats

Cheng, Y., Wang, C., Lin, H.-B., Li, Y., Huang, Y., Xu, J., & Zhang, H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1943-3 · Cited by 99 · see citing works

The Role of Phosphodiesterases in Schizophrenia

Siuciak, J. A. (2008) · CNS Drugs · doi:10.2165/0023210-200822120-00002 · Cited by 98 · see citing works

Synaptic plasticity in Alzheimer’s disease and healthy aging

Torres, D. M. C., & Cárdenas, F. P. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0058 · Cited by 98 · see citing works

Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy

Nisticò, R., Pignatelli, M., Piccinin, S., Mercuri, N. B., & Collingridge, G. L. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8324-3 · Cited by 97 · see citing works

In Vivo Pharmacological Characterization of a Novel Selective α7 Neuronal Nicotinic Acetylcholine Receptor Agonist ABT-107: Preclinical Considerations in Alzheimer's Disease

Bitner, R. S., Bunnelle, W. H., Decker, M. W., Drescher, K. U., Kohlhaas, K. L., Markosyan, S., Marsh, K. C., Nikkel, A. L., Browman, K., Radek, R., et al. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167213 · Cited by 97 · see citing works

PDE4B as a microglia target to reduce neuroinflammation

Pearse, D. D., & Hughes, Z. A. (2016) · Glia · doi:10.1002/glia.22986 · Cited by 97 · see citing works

Failures to reconsolidate memory in a mouse model of Alzheimer’s disease

Ohno, M. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2009.05.001 · Cited by 95 · see citing works

Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25–35 or Aβ1–40 peptide in rats

Cheng, Y., Wang, C., Lin, H.-B., Li, Y., Huang, Y., Xu, J., & Zhang, H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1943-3 · Cited by 99 · see citing works

Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling

Vitolo, O. V., Sant'Angelo, A., Costanzo, V., Battaglia, F., Arancio, O., & Shelanski, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172504199 · Cited by 534 · see citing works

Inhibition of phosphodiesterase-4 reverses the cognitive dysfunction and oxidative stress induced by Aβ25–35 in rats

Zhuo, Y., Guo, H., Cheng, Y., Wang, C., Wang, C., Wu, J., Zou, Z., Gan, D., Li, Y., & Xu, J. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9814-1 · Cited by 25 · see citing works

The phosphodiesterase-4 inhibitor rolipram reverses Aβ-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats

Wang, C., Yang, X., Zhuo, Y., Zhou, H., Lin, H.-B., Cheng, Y., Xu, J., & Zhang, H. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000836 · Cited by 150 · see citing works

Rolipram Ameliorates Memory Deficits and Depression-Like Behavior in APP/PS1/tau Triple Transgenic Mice: Involvement of Neuroinflammation and Apoptosis via cAMP Signaling

Cong, Y.-F., Liu, F.-W., Xu, L., Song, S., Shen, X.-R., Liu, D., Hou, X.-Q., & Zhang, H. (2023) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyad042 · Cited by 38 · see citing works